Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | 0.00% | +9.79% | -22.46% |
05-09 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.46% | 206M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.40% | 22.27B | |
-12.64% | 22.22B | |
-5.15% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- RBC Trims bluebird bio's Price Target to $6 From $8, Keeps Sector Perform Speculative Risk Rating